In a discussion panel on whether the industry's latest boom will last, a prominent investor, Oleg Nodelman, joked that he still had suitcases of cash for any firm that wanted it.Biotechnology is the creation of drugs and other useful products by making use of "nature's toolkit"—that is, by adapting or exploiting processes found in living organisms.
Such exploiting processes can be classified as Direct Modeling, an emerging technical term in the CAD industry [20 24] that has appeared frequently, in contrast to Parametric Modeling, for almost a decade.
Ben Seri, vice president of research at Armis, said that the exploit process is "relatively straight forward".
But he warned that the Bluetooth-based attack can be just one part of a wider exploit process.
In contrast to conventional (static), data-driven multi-class machine learning (ML), we exploit process knowledge in order to constrain our classification system yielding more parsimonious models compared to static ML approaches.
Shares in biotech companies, which adapt and exploit processes found in living organisms to create drugs and other useful products, have also taken a beating.
Industrial biotechnology exploits processes that use living cells, for instance yeast and various bacteria, to produce products like fine chemicals, active pharmaceutical ingredients, enzymes, and biofuels.
However, the fact that loss and gain of stem cells occurs opens the possibility of a transformed stem cell exploiting this process in its favor and achieving clonal dominance.
The phenomenon of RNAi silencing is widely conserved among all higher eukaryotes, and exploiting this process is becoming increasingly important as an experimental tool, as well as for therapeutic applications.
